Since May 2010, Imperial researchers have been recruiting 2,000 volunteers to participate in a study on a polypill. This polypill shall help people who have a heart condition and are at risk of stroke or heart attack. According the Reporter (Issue 220), Imperial's news magazine, the following aims are pursued:
-Reducing risk of cardiovascular problems by reducing blood pressure and lowering cholesterol,
-Combining medications in one,
-Enabling people in low-income countries to have access to cheap preventive medication,
-Allowing people easy preventive treatment.
The pill is to take once a day and contains aspirin in a low dose, a statin and blood pressure-lowering medication. Because of its all-in-one nature, it is expected to be much cheaper.
Seemingly, the cost effect is the main drive to this study. Generally, it is a noble intention, but hopefully people will not forget to live in such a way that heart medication is not needed in the first place.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment